| Ethics Information |
Forms |
|
Western Health has decided to manage approval of research as a three-tier process:
1) Quality Assurance Applications: via the Low Risk Human Research Ethics Panel - To be approved by a single member of the panel and tabled at panel meetings.
2) Negligible and Low Risk Applications: via the Low Risk Human Research Ethics Panel - To be approved by the panel at monthly meetings.
3) Higher Risk Applications: via the Melbourne Health Human Research Ethics Committee - To be approved by the committee at monthly meetings.
The Western Health Low Risk Human Research Ethics Panel is constituted according to the requirements of the National Health and Medical Research Council of Australia (NHMRC). The function of this panel is to consider the ethical implications of research applications submitted to the panel for review and to evaluate the ethical conduct of the research. The panel will be responsible for review of all quality assurance, negligible risk and low risk research from the Western Health Network.
Members and Terms of Reference of the Western Health Low Risk Human Research Ethics Panel:
Members and tof web.pdf
Application Management
A turnaround time from submission of application to outcome will be no more than two weeks for quality assurance applications and within one week of the subsequent panel meeting for all other applications. To comply with timelines for quality assurance applications, these projects will be reviewed outside of panel meetings.
Meetings Dates and Assocciated Application Submission Deadlines:
2010 Meeting dates TBA
|
What is a Quality Assurance Project? (Information and Application Form) Quality Assurance Application FormV2.doc (281KB)Quality Assurance Participant Information and Consent Form Template Quality Assurance Participant Information and Consent Form.doc
What is Low and Negligible Risk Research?
ID low risk web.pdf
Low Risk Application Form
Low Risk Application fromV3.doc (464KB)
Participant Information and Consent Form Template
Participant Information and Consent FormV2.doc (267KB)
Participant Information Template
Projects requiring ANY use of pathology services: Please complete the WH Pathology Research Questionnaire prior to project submission, as approval from pathology will be required in order to submit your application. Pathology Research Questionnaire
Module Three: Projects Involving Use of Human Tissue Samples (including blood samples) Low Risk Module Three FormV2.doc (313KB) Module Three Guidelines mod three Gl web.pdf
Research Protocol Guidelines Res Protocol GL web.pdf
Privacy Legislation Adherence Guidelines Priv Leg Ad GL web.pdf
Project Reporting:
Biannual. Final Report.doc
Adverse Event Report Form.doc
Protocol Violation Report.doc
Amendment Request.doc
Privacy Statement | Disclaimer Powered by OBJECTIFY
|
|
|
|
Please Note:
The Office for Research at Western Health will be temporarily unmanned. For all queries please follow the contact information below:
Urgent Western Health Research Queries:
Please email the Director of Research: Dr David Newman on: david.newman@wh.org.au
Queries relating to New Research Project applications:
All queries for ethical approval should be directed to The Melbourne Health Office for Research who will be able to conduct ethical approval on behalf of Western Health for all Single and Multi-site projects.
Please note the proceedings of the Western Health Low Risk Human Research Ethics Panel have been temporarily suspended. Please contact the Office for Research on: (03) 83451504 after 1st June or check the following website link: http://www.westernhealth.org.au/Research/Ethics/index.aspx for future meeting dates.
Queries relating to Research Projects that have been Approved by the Western Health Low Risk Human Research Ethics Panel:
Please call Kerrie Russell on: (03) 8345 1504 or email: kerrie.russell@wh.org.au
Urgent Research Queries which may have an Immediate Impact on the Health and Safety of Participants at Western Health:
Please call: 03 8345 6420 - (this number will be manned during office hours, Monday to Friday where Dr Mark Garwood, Acting Director of Medical Services, can be contacted).